Dr. Reddy's Laboratories Limited (BOM:500124)
India
· Delayed Price · Currency is INR 1,286.40
-17.50 (-1.34%)
At close: Mar 9, 2026
Dr. Reddy's Laboratories Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 1,071,032 | 953,168 | 1,024,969 | 767,655 | 714,500 | 749,317 | Upgrade
|
| Market Cap Growth | 7.50% | -7.00% | 33.52% | 7.44% | -4.65% | 45.01% | Upgrade
|
| Enterprise Value | 1,059,565 | 948,175 | 972,270 | 736,818 | 707,464 | 753,909 | Upgrade
|
| Last Close Price | 1286.40 | 1136.84 | 1216.07 | 905.98 | 838.27 | 875.17 | Upgrade
|
| PE Ratio | 18.94 | 16.86 | 18.41 | 17.03 | 30.32 | 43.47 | Upgrade
|
| Forward PE | 21.34 | 15.36 | 19.12 | 19.56 | 23.75 | 25.06 | Upgrade
|
| PS Ratio | 3.10 | 2.93 | 3.67 | 3.12 | 3.33 | 3.95 | Upgrade
|
| PB Ratio | 2.85 | 2.83 | 3.65 | 3.32 | 3.75 | 4.33 | Upgrade
|
| P/TBV Ratio | 4.16 | 4.24 | 4.28 | 3.92 | 4.50 | 5.64 | Upgrade
|
| P/FCF Ratio | 29.22 | 50.37 | 35.31 | 16.14 | 53.13 | 28.86 | Upgrade
|
| P/OCF Ratio | 16.97 | 20.53 | 22.56 | 13.04 | 25.42 | 20.99 | Upgrade
|
| PEG Ratio | 6.74 | 2.87 | 1.13 | 0.95 | 1.13 | 1.93 | Upgrade
|
| EV/Sales Ratio | 3.06 | 2.91 | 3.48 | 3.00 | 3.30 | 3.97 | Upgrade
|
| EV/EBITDA Ratio | 12.30 | 10.67 | 12.26 | 11.16 | 14.82 | 16.50 | Upgrade
|
| EV/EBIT Ratio | 15.91 | 12.98 | 14.82 | 13.79 | 19.70 | 22.91 | Upgrade
|
| EV/FCF Ratio | 28.91 | 50.10 | 33.49 | 15.50 | 52.61 | 29.04 | Upgrade
|
| Debt / Equity Ratio | 0.18 | 0.14 | 0.07 | 0.06 | 0.18 | 0.18 | Upgrade
|
| Debt / EBITDA Ratio | 0.79 | 0.52 | 0.25 | 0.20 | 0.71 | 0.66 | Upgrade
|
| Debt / FCF Ratio | 1.85 | 2.47 | 0.69 | 0.28 | 2.52 | 1.17 | Upgrade
|
| Net Debt / Equity Ratio | -0.04 | -0.03 | -0.22 | -0.21 | -0.05 | -0.02 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.17 | -0.12 | -0.77 | -0.73 | -0.22 | -0.09 | Upgrade
|
| Net Debt / FCF Ratio | -0.40 | -0.59 | -2.12 | -1.02 | -0.78 | -0.16 | Upgrade
|
| Asset Turnover | 0.66 | 0.74 | 0.79 | 0.80 | 0.77 | 0.76 | Upgrade
|
| Inventory Turnover | 2.06 | 2.01 | 2.06 | 2.14 | 2.09 | 2.15 | Upgrade
|
| Quick Ratio | 1.18 | 1.16 | 1.72 | 1.58 | 1.24 | 1.07 | Upgrade
|
| Current Ratio | 1.88 | 1.92 | 2.58 | 2.38 | 1.93 | 1.78 | Upgrade
|
| Return on Equity (ROE) | 16.10% | 18.53% | 21.77% | 21.38% | 12.96% | 10.51% | Upgrade
|
| Return on Assets (ROA) | 7.96% | 10.37% | 11.56% | 10.86% | 8.04% | 8.27% | Upgrade
|
| Return on Invested Capital (ROIC) | 14.38% | 19.98% | 25.30% | 21.99% | 15.03% | 13.42% | Upgrade
|
| Return on Capital Employed (ROCE) | 16.40% | 20.10% | 22.50% | 22.60% | 18.10% | 18.10% | Upgrade
|
| Earnings Yield | 5.28% | 5.93% | 5.43% | 5.87% | 3.30% | 2.30% | Upgrade
|
| FCF Yield | 3.42% | 1.98% | 2.83% | 6.19% | 1.88% | 3.46% | Upgrade
|
| Dividend Yield | 0.61% | 0.70% | 0.66% | 0.88% | 0.72% | 0.57% | Upgrade
|
| Payout Ratio | 11.77% | 11.78% | 11.94% | 11.05% | 17.59% | 24.06% | Upgrade
|
| Buyback Yield / Dilution | 0.15% | -0.08% | -0.19% | -0.03% | -0.01% | -0.14% | Upgrade
|
| Total Shareholder Return | 0.77% | 0.63% | 0.47% | 0.85% | 0.70% | 0.43% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.